Monday, August 4th, 2025

Singapore Alpha Picks August 2025: Top Stocks Outperforming STI – Key Picks, Portfolio Strategy & Market Insights | UOB Kay Hian

UOB Kay Hian
Date of Report: 4 August 2025

Singapore Alpha Stock Picks: July Outperformance, August Opportunities, and Key Catalysts for 2025

UOB Kay Hian’s latest strategy update showcases a stellar performance for its Alpha Picks portfolio in July 2025, achieving a 17.7% month-on-month (mom) gain and outperforming the Straits Times Index (STI) by 12.4 percentage points. As Singapore’s market momentum accelerates, fueled by the MAS S\$5 billion equity market development program and robust IPO activity, investors are presented with refreshed insights and actionable recommendations for August 2025.

Market Overview: Record-Breaking Returns and Small-Mid Cap Surge

July 2025 marked a bullish period for Singapore equities with the STI hitting record highs. The Alpha Picks portfolio’s outperformance was driven by a strategic focus on small and mid-cap companies, which benefited from positive news about Singapore’s S\$5 billion equity market development program (EDQP) and revitalized local bourse sentiment.

  • Alpha Picks Portfolio Returns (July 2025):
    • Equal-weighted: +17.7% mom
    • Market cap-weighted: +6.0% mom
    • Price-weighted: +14.6% mom
  • FSSTI Return: +5.3% mom
  • Alpha Picks outperformed FSSTI 12 out of the past 15 months

The portfolio’s gains were led by non-index stocks, positioning it to benefit from the MAS S\$5 billion capital injection expected in the second half of 2025.

Portfolio Adjustments for August 2025

With the anticipated MAS capital deployment, UOB Kay Hian adds three new small-mid cap stocks:

  • Hong Leong Asia (HLA): Favourable construction sector outlook
  • Marco Polo Marine (MPM): High charter rates and vessel utilization
  • CSE Global (CSE): Robust and expanding orderbook

The portfolio exits iFAST (+40.7% since addition) and Sheng Siong Group (+19.3%) to lock in profits. The current Alpha Picks portfolio now comprises CLAR, CICT, CSSC, CD, CSE, DFI, FEH, FRKN, HLA, MPM, OCBC, PROP, UMSH, and VALUE.

Performance and Returns Table

Company Rec Price (S\$) 1 Aug Target Price (S\$) Up/Down to TP (%) Jul-25 Return (%) To Date Return (%)
CL Ascendas Reit BUY 2.74 4.02 46.7 4.1 0.4
CL Int Com T BUY 2.19 2.72 24.2 1.4 10.6
ChinaSunsine BUY 0.73 0.63 (13.7) 28.4 32.7
ComfortDelGro BUY 1.52 1.71 12.5 7.0 7.8
CSE Global BUY 0.65 0.61 (5.4)
DFIRG USD BUY 3.43 4.30 25.4 25.4 44.1
Food Empire BUY 2.32 2.40 3.4 27.7 33.3
Frencken BUY 1.65 1.40 (15.2) 33.9 44.7
Hong Leong Asia BUY 1.68 1.93 14.9
Marco Polo Marine BUY 0.056 0.066 17.9
OCBC BUY 16.79 20.15 20.0 3.4 35.7
PropNex BUY 1.43 1.35 (5.6) 27.8 33.6
UMS BUY 1.53 1.73 13.1 15.0 12.5
Valuetronics BUY 0.79 0.83 5.1 6.2 13.7

In-Depth Company Analysis and Catalysts

PropNex: Bullish Outlook with Strong Transaction Volumes

  • CEO Ismail Gafoor maintains a bullish outlook despite recent adjustments to Seller’s Stamp Duty (SSD) rates, which are not expected to significantly impact transaction volumes or prices.
  • 1H25 revenue is forecast at S\$501 million (+45% yoy, +15% hoh), net profit S\$27 million (+42% yoy, +23% hoh), reflecting robust activity in both public and private residential markets.
  • Target price: S\$1.35; 17.6x PE (above historical average).
  • Catalysts: Strong new property launches, price increments in private and HDB resale, potential special dividend in 1H25.

DFI Retail: Turnaround and Growth Prospects

  • 1H25 underlying profit at US\$105 million (+39% yoy), supported by health & beauty and food divisions and higher associate contributions.
  • Balance sheet moved from US\$549 million net debt (1H24) to US\$443 million net cash (1H25).
  • Raised 2025 profit guidance to US\$250-270 million (19–34% yoy growth expected).
  • Target price: US\$4.30; 22.7x PE (below 10-year average).
  • Catalysts: Continued sales momentum, successful launch of high-margin products, accretive acquisitions, monetizing its “yuu” data platform.

ComfortDelGro: Margin Expansion and Dividend Yield

  • UK bus margins expected to remain at 10–15% in 2025, with more contract renewals anticipated from 2Q25 onward.
  • Domestic rail ridership improvement and fare increase from Dec 2024 to boost rail revenue.
  • Taxi business supported by acquisitions (A2B, Addison Lee), offsetting competitive pressures and subdued China rentals.
  • Target price: S\$1.71; 16x 2025F PE; 5.8% yield.
  • Catalysts: Bus contract wins, taxi commission increases, accretive overseas acquisitions.

Hong Leong Asia: Construction Boom Proxy

  • 20% market share in Singapore’s ready-mix concrete (RMC) sector.
  • Malaysia construction market uptrend continues; 1Q25 construction work completed at RM42.9 billion (+16.6% yoy).
  • Major infrastructure projects (MRT3, Pan Borneo, HSR, Sabah-Sarawak Link) to drive demand.
  • Target price: S\$1.93; SOTP-based valuation (BMU at 7x, Diesel Engines at 8x 2025F EV/EBITDA).
  • Catalysts: Stronger-than-expected dividends, earnings surprise in engine/materials sales.

Marco Polo Marine: Offshore Wind and Fleet Expansion

  • Key deployment: CSOV “MP Wind Archer” for Siemens (Taiwan wind farm) in 2HFY25. Premium short-term charter rates expected to boost earnings.
  • Three new Crew Transfer Vessels (CTVs) to be deployed in 3Q25.
  • Shipyard recovery expected with new dry dock expanding repair capacity by 25%.
  • Strong net cash position (S\$46 million) and NAV per share of S\$0.056.
  • Target price: S\$0.066; 9.5x FY25F PE.
  • Catalysts: Higher-than-expected charter rates, new contracts, shipyard recovery.

China Sunsine Chemical: Automotive Demand Drives Growth

  • World’s largest rubber accelerator producer (117,000 tonnes annual capacity).
  • Strong vehicle sales in China (CAAM projects 2025 sales up 4.7% yoy).
  • Declared 5.2% dividend yield, net cash RMB2,074 million (70% of market cap).
  • Target price: S\$0.63; 7.5x 2025F PE, 1.3x ex-cash PE.
  • Catalysts: New capacity production, higher ASPs, utilization rates.

Food Empire Holdings: Instant Coffee Expansion

  • Market leader in Russia, Kazakhstan and top 3 in Vietnam.
  • New facilities in Vietnam, Kazakhstan, Malaysia to boost output.
  • Supplemental REN agreement removes earnings volatility from 3Q25.
  • 2024 revenue up 16% yoy, fourth consecutive year of growth.
  • Target price: S\$2.40; 17x 2026F PE (+2SD to mean).
  • Catalysts: Dividend surprise, volume growth, margin improvement.

CSE Global: Orderbook Strength and US Expansion

  • Orderbook at S\$616 million (end-1Q25), strong momentum in communications and automation.
  • Chicago Communications acquisition (US\$8.5 million) to boost US presence and earnings.
  • Divested US industrial property for US\$29.25 million, generating ~US\$9 million post-tax gain.
  • Target price: S\$0.61; 11x 2025F PE; 5.4% yield.
  • Catalysts: Large project wins, further accretive M&A.

Frencken: Semiconductor Rebound and Diversification

  • 2Q25 earnings forecast at S\$10 million (+10% yoy), driven by semiconductor and medical segments.
  • Key customers ASML and Applied Materials posted strong 2Q25 results, signaling robust demand.
  • Limited tariff impact (9% of 2024 revenue from US, mostly from Singapore).
  • Target price: S\$1.40; 15x 2025F PE (+1SD above mean).
  • Catalysts: Factory utilization, cost management improvements.

Valuetronics: Resilient Outlook and Shareholder Focus

  • Profitable in FY26 despite global uncertainties; expansion of Vietnam facility by 30% underway.
  • Net cash HK\$1.1 billion (~S\$180 million, 65% of market cap); dividend payout historically higher than formal policy.
  • Target price: S\$0.83; 11x FY26 PE; 3x ex-cash PE; 6.8% dividend yield.
  • Catalysts: Higher dividends, M&A activity, proactive management.

UMS Integration: Semiconductor Upside and Bursa Listing

  • New customer orders and stable demand from established clients; 2Q25 earnings forecast at S\$11 million (+12% yoy).
  • Dual listing on Bursa Malaysia to unlock valuation re-rating (aiming to close 25% gap vs Malaysian peers).
  • Global semiconductor market expected to grow double-digit in 2025, supporting core business and aerospace segment.
  • Target price: S\$1.73; 23x 2026F EPS (2SD above mean); ~4% dividend yield.
  • Catalysts: Factory utilization, return of aircraft component orders, Bursa valuation uplift.

Capitaland Ascendas REIT: Preferential Tariffs and Data Centre Growth

  • Largest exposure to business parks and hi-tech buildings (53% of portfolio), with technology, logistics, and life sciences contributing 65.1% of rental income.
  • Acquisition of 9 Tai Seng Drive (Tier III data centre) with 7.1% NPI yield, potential for rental uplift and expansion.
  • Target price: S\$4.02 (DDM-based, 6.5% COE, 2.5% terminal growth).
  • Catalysts: Growth across business parks, hi-tech, logistics, data centres, and AEIs.

Oversea-Chinese Banking Corp (OCBC): Capital Management and Dividend Upside

  • Announced plan to return S\$2.5 billion excess capital via special dividends (10% of net profit for 2024 & 2025) and share buybacks.
  • CET-1 CAR at 15.3% (highest among Singapore banks), strong potential for inorganic growth.
  • Target price: S\$20.15; 1.44x 2025F P/B.
  • Catalysts: Attractive 2025 dividend yield (5.8%), buyback program support.

Capitaland Integrated Commercial Trust: Mall Revamps and Rental Upside

  • Tampines Town Central rejuvenation to drive rental uplift; reconfiguration of Isetan space at Tampines Mall into specialty units.
  • AEI for ION Orchard to enhance layout and luxury brand positioning, with works staggered through 2025/26.
  • Stable cost of debt (3.4%); target price: S\$2.72 (DDM-based).
  • Catalysts: Portfolio growth, AEI completions in Singapore and Frankfurt.

Valuation Table (Key Metrics)

Company Ticker Rec Price (S\$)
1 Aug 25
Target Price (S\$) Upside (%) PE 2024A PE 2025E PE 2026E Yield 2025E (%) ROE 2025E (%) Market Cap (S\$m) Price/NAV
CapLand Ascendas Reit CLAR SP BUY 2.74 4.02 46.7 17.9 18.6 17.3 5.6 6.3 12,621.2 1.2
CapLand IntCom T CICT SP BUY 2.19 2.72 24.2 20.1 19.0 18.5 5.0 5.4 16,024.6 1.0
ChinaSunsine CSSC SP BUY 0.73 0.63 (13.7) 8.9 8.8 8.5 4.0 9.9 696.0 0.9
ComfortDelGro CD SP BUY 1.52 1.71 12.5 15.6 14.5 12.9 5.7 8.7 3,293.5 1.3
CSE Global CSE SP BUY 0.65 0.61 (5.4) 16.5 11.6 11.1 3.7 14.1 461.6 1.8
DFIRG USD DFI SP BUY 3.43 4.30 25.4 n.a. 18.5 18.0 16.4 40.4 6,029.4 7.5
Food Empire FEH SP BUY 2.32 2.40 3.4 17.4 17.4 16.2 3.3 17.3 1,225.7 3.0
Frencken FRKN SP BUY 1.65 1.40 (15.2) 19.0 17.7 16.7 1.7 8.9 704.7 1.6
Hong Leong Asia HLA SP BUY 1.68 1.93 14.9 14.3 11.1 10.0 3.0 10.7 1,256.9 1.2
MarcoPolo Marine MPM SP BUY 0.056 0.066 17.9 9.7 8.1 6.6 3.6 13.4 210.2 1.1
OCBC OCBC SP BUY 16.79 20.15 20.0 10.1 10.5 10.0 5.8 11.9 75,492.3 1.3
PropNex PROP SP BUY 1.43 1.35 (5.6) 25.9 19.8 18.8 4.2 41.4 1,058.2 8.6
UMS UMSH SP BUY 1.53 1.73 13.1 26.7 23.0 20.3 3.3 11.2 1,087.1 2.6
Valuetronics VALUE SP BUY 0.79 0.83 5.1 11.1 10.9 10.4 5.9 11.8 320.5 1.3

Conclusion: Positioning for Outperformance in 2H25

UOB Kay Hian’s Alpha Picks portfolio remains focused on high-growth, small-mid cap opportunities, leveraging sectoral tailwinds, robust orderbooks, and strategic catalysts across Singapore’s equity landscape. With the MAS S\$5 billion capital injection on the horizon, the Alpha Picks continue to offer investors a well-positioned, diversified basket of conviction names for outperformance in the months ahead.

Market Highlights HK:3115.HK:Hangseng Index Hang Seng Index Climbs 185 Points Midday, Tech and PV Stocks Lead Rally The Hang Seng Index rose 185 points to 24,073 at midday, led by tech stocks. HK:1024.HK:KUAISHOU-W jumped...

Akeso, Inc. (9926 HK): A Revolutionary Player in Lung Cancer Treatment

Akeso, Inc. (9926 HK): A Revolutionary Player in Lung Cancer Treatment Ivonescimab: A Game Changer in First-Line Lung Cancer Treatment Akeso Inc. continues to make headlines in the biotechnology sector, particularly with its groundbreaking...

Sailing into New Horizons: Mermaid Maritime Secures Record-Breaking Orders

Date: September 30, 2024Broker Name: CGS-CIMB Securities Orderbook at an 11-Year High As of 2Q24, Mermaid Maritime’s (MMT) orderbook reached an impressive US$976 million, the highest in 11 years. This substantial orderbook increase is...